Apollomics (United States)

Recent papers from Apollomics (United States)

1. IBT-16plex-Based Quantitative Proteomics at the Single-Cell Level: Enabling Protein Profiles toward the Single Cells from Mouse SpleenAnalytical Chemistry · 2025
2. IBT-16plex-Based Quantitative Proteomics at the Single-Cell Level: Enabling Protein Profiles toward the Single Cells from Mouse SpleenAnalytical Chemistry · 2025
3. Mass Spectrometry-Based Comparative Analysis of N -Glycosylation Alterations in Three Human Body Fluids in Parkinson’s DiseaseACS Chemical Neuroscience · 2025
4. Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET RearrangementsCancer Discovery · 2025
5. Mass Spectrometry-based Solutions for Single-cell ProteomicsGenomics Proteomics & Bioinformatics · 2025
6. Enrichment of glycoRNAs using galactose oxidase, hydrazide chemistry, and glycosidase digestion2024
7. Abstract 6500: Dependence of EGFR-mutant NSCLC on MET as demonstrated by vebreltinib, a novel and selective brain-penetrating MET kinase inhibitorCancer Research · 2024
8. Abstract 597: Vebreltinib: A novel brain-penetrating MET kinase inhibitor demonstrates the mechanism of action and pharmacological anti-tumor activity in diverse patient-derived MET-dysregulated tumor models at clinically relevant drug levelsCancer Research · 2024
9. Immunomodulator FTY720 improves glucose homeostasis and diabetic complications by rejuvenation of β‐cell function in nonhuman primate model of diabetesFundamental and Clinical Pharmacology · 2022